Skip to main content
Home

Radiologists worry that anti-DEI legislative efforts could exacerbate staffing shortages

"This reduced talent pool, coupled with increasing demands in radiology, will negatively affect the quality and access to care for patients," experts wrote in JACR. 

  • Read more about Radiologists worry that anti-DEI legislative efforts could exacerbate staffing shortages

Outpatient radiology providers missing the mark when communicating costs to patients

medical billing_5.jpg

About 17% of healthcare consumers were aware of one health system's estimator tool, but 0% had used it, according to new survey data. 

  • Read more about Outpatient radiology providers missing the mark when communicating costs to patients

Johns Hopkins, CareFirst partner with venture capital for ‘AI accelerator’ program

artificial intelligence AI money brain dollar

The 13-week course will be held in Baltimore sometime in March 2025. Healthcare AI startups have until Nov. 20 to apply.

  • Read more about Johns Hopkins, CareFirst partner with venture capital for ‘AI accelerator’ program

Cardiac CT outperforms stress tests when screening liver transplant candidates for CAD

Coronary CT Angiography (CCTA) has evolved into a much more helpful resource than interventional cardiologists may have originally believed. In fact, the Society of Cardiovascular Computed Tomography (SCCT) emphasized in a new expert consensus statement that CCTA provides specialists with an effective tool in the preparation and optimization of coronary procedures. The 2021 chest pain guidelines elevated CTA to a class 1A recommendation. Harold Litt , MD, explains the use of CCTA in the ED.

Heart issues are the No. 1 cause of death for liver transplant patients. Screening patients for signs of CAD is one way care teams can help keep such complications to a minimum. 

  • Read more about Cardiac CT outperforms stress tests when screening liver transplant candidates for CAD

CRF announces late-breaking clinical trials for TCT 2024

TCT 2024 TCT 2023 crowd

The packed crowd looks on during late-breaking clinical trial presentations at TCT 2023.

The Cardiovascular Research Foundation has announced 10 late-breaking clinical trials and 15 late-breaking clinical science sessions for TCT 2024 in Washington, DC. Topics will include TAVR and other structural heart procedures, artificial intelligence and much more. 

  • Read more about CRF announces late-breaking clinical trials for TCT 2024

Maryland hospital settles ransomware lawsuit for $2.25M

A cardiology practice in Florida and several of its cardiologists have agreed to pay $2 million to resolve allegations that they violated the False Claims Act and committed fraud. As a part of the agreement, there has been no determination of liability.

Atlanta General Hospital does not admit wrongdoing. However, it has agreed to settle a class-action lawsuit brought by victims of a January 2023 data breach.

  • Read more about Maryland hospital settles ransomware lawsuit for $2.25M

New PET technique slashes scan times, improves image quality in neuroblastoma cases

New PET technique improves imaging of pediatric neuroblastoma.

Image courtesy of the Journal of Nuclear Medicine.

The method also reduces radiation doses and eliminates the need for sedation or general anesthesia.

  • Read more about New PET technique slashes scan times, improves image quality in neuroblastoma cases

PaceMate acquires Medtronic workflow tech, promising ‘unparalleled support’ for heart patients

doctor examines patient data on their tablet

The Florida-based healthcare company, already a leading name in cardiac data management, said the acquisition will help its technology reach more heart teams than ever before.

  • Read more about PaceMate acquires Medtronic workflow tech, promising ‘unparalleled support’ for heart patients

Odds of late-stage cancer diagnosis double when women put off annual breast cancer screening

breast-cancer-ribbon-gty-mem-180412_hpmain_16x9_608.jpg

Biennial and intermittent screening also significantly decrease rates of overall survival, a new analysis shows.

  • Read more about Odds of late-stage cancer diagnosis double when women put off annual breast cancer screening

Medicare coverage for weight loss drug semaglutide could cost up to $145B per year

Semaglutide (Wegovy) injector pen. Photo by Dave Fornell

Medications that target obesity are not typically covered by Medicare. When the FDA approved semaglutide as a way to treat certain cardiovascular risks, however, CMS said Medicare coverage was on the table. 

  • Read more about Medicare coverage for weight loss drug semaglutide could cost up to $145B per year

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …510
    • Page 511
    • Page 512
    • Page 513
    • Current page 514
    • Page 515
    • Page 516
    • Page 517
    • Page 518 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme